Bank of America
RIGL icon

Bank of America’s Rigel Pharmaceuticals RIGL Stock Holding History

Bank of America’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.9M Buy
144,131
+27,179
+23% +$913K ﹤0.01% 3645
2025
Q4 		$5.01M Buy
116,952
+41,476
+55% +$1.56M ﹤0.01% 3391
2025
Q3 		$2.14M Sell
75,476
-112,145
-60% -$3.35M ﹤0.01% 4771
2025
Q2 		$3.51M Buy
187,621
+55,184
+42% +$1.05M ﹤0.01% 4244
2025
Q1 		$2.38M Buy
132,437
+100,271
+312% +$2.03M ﹤0.01% 4527
2024
Q4 		$541K Buy
32,166
+3,520
+12% +$67.5K ﹤0.01% 5471
2024
Q3 		$463K Buy
28,646
+11,741
+69% +$138K ﹤0.01% 5535
2024
Q2 		$139K Buy
16,905
+5,701
+51% +$59.7K ﹤0.01% 6081
2024
Q1 		$166K Sell
11,204
-5,842
-34% -$78.7K ﹤0.01% 5982
2023
Q4 		$247K Buy
17,046
+7,200
+73% +$73.6K ﹤0.01% 5958
2023
Q3 		$106K Buy
9,846
+357
+4% +$4.29K ﹤0.01% 6230
2023
Q2 		$122K Sell
9,489
-7,075
-43% -$95.7K ﹤0.01% 6115
2023
Q1 		$219K Sell
16,564
-1,920
-10% -$30.5K ﹤0.01% 5879
2022
Q4 		$277K Sell
18,484
-11,748
-39% -$108K ﹤0.01% 5742
2022
Q3 		$356K Sell
30,232
-82,098
-73% -$1.11M ﹤0.01% 5626
2022
Q2 		$1.27M Buy
112,330
+84,818
+308% +$1.7M ﹤0.01% 4690
2022
Q1 		$822K Buy
27,512
+2,513
+10% +$68K ﹤0.01% 5429
2021
Q4 		$663K Sell
24,999
-5,016
-17% -$151K ﹤0.01% 5629
2021
Q3 		$1.09M Buy
30,015
+316
+1% +$12.4K ﹤0.01% 4983
2021
Q2 		$1.29M Buy
29,699
+7,670
+35% +$290K ﹤0.01% 4679
2021
Q1 		$754K Buy
22,029
+19,395
+736% +$768K ﹤0.01% 5056
2020
Q4 		$92K Sell
2,634
-944
-26% -$27.3K ﹤0.01% 6027
2020
Q3 		$86K Sell
3,578
-3,040
-46% -$74.6K ﹤0.01% 5775
2020
Q2 		$121K Buy
6,618
+1,623
+32% +$29.2K ﹤0.01% 5580
2020
Q1 		$78K Sell
4,995
-1,574
-24% -$33.5K ﹤0.01% 5659
2019
Q4 		$140K Sell
6,569
-3,986
-38% -$82.1K ﹤0.01% 5837
2019
Q3 		$197K Sell
10,555
-13,228
-56% -$273K ﹤0.01% 5678
2019
Q2 		$621K Sell
23,783
-83,874
-78% -$1.89M ﹤0.01% 4918
2019
Q1 		$2.77M Buy
107,657
+49,062
+84% +$1.12M ﹤0.01% 3723
2018
Q4 		$1.35M Buy
58,595
+54,393
+1,294% +$1.54M ﹤0.01% 4171
2018
Q3 		$135K Sell
4,202
-29,390
-87% -$882K ﹤0.01% 5720
2018
Q2 		$950K Buy
33,592
+4,013
+14% +$143K ﹤0.01% 4501
2018
Q1 		$1.05M Buy
29,579
+24,484
+481% +$980K ﹤0.01% 4351
2017
Q4 		$198K Buy
5,095
+313
+7% +$11.9K ﹤0.01% 5417
2017
Q3 		$121K Buy
4,782
+1,885
+65% +$45.8K ﹤0.01% 5598
2017
Q2 		$79K Sell
2,897
-8,131
-74% -$223K ﹤0.01% 5695
2017
Q1 		$365K Sell
11,028
-24,662
-69% -$628K ﹤0.01% 5049
2016
Q4 		$850K Buy
35,690
+20,465
+134% +$586K ﹤0.01% 4464
2016
Q3 		$559K Buy
15,225
+12,865
+545% +$369K ﹤0.01% 4549
2016
Q2 		$53K Buy
2,360
+1,283
+119% +$31.9K ﹤0.01% 5813
2016
Q1 		$22K Sell
1,077
-1,722
-62% -$42.5K ﹤0.01% 6097
2015
Q4 		$85K Buy
2,799
+2,475
+764% +$75K ﹤0.01% 5801
2015
Q3 		$8K Sell
324
-221
-41% -$6.59K ﹤0.01% 6643
2015
Q2 		$17K Buy
545
+316
+138% +$12.1K ﹤0.01% 6393
2015
Q1 		$8K Buy
229
+193
+536% +$5.29K ﹤0.01% 6375
2014
Q4 		$1K Sell
36
-6,347
-99% -$128K ﹤0.01% 7564
2014
Q3 		$124K Buy
6,383
+2,823
+79% +$79.7K ﹤0.01% 5828
2014
Q2 		$129K Buy
3,560
+226
+7% +$7.68K ﹤0.01% 5926
2014
Q1 		$129K Sell
3,334
-10,590
-76% -$378K ﹤0.01% 5770
2013
Q4 		$397K Buy
13,924
+7,921
+132% +$233K ﹤0.01% 4953
2013
Q3 		$215K Buy
6,003
+912
+18% +$33.3K ﹤0.01% 5385
2013
Q2 		$170K Buy
+5,091
New +$231K ﹤0.01% 5772

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's RIGL Position: Q1 2026 in Review

Bank of America increased its Rigel Pharmaceuticals (RIGL) stake by 23% in Q1 2026, buying an estimated $913K and bringing the position to 144,131 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3645.

Bank of America first reported a position in RIGL in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.01M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Bank of America held 144,131 shares of Rigel Pharmaceuticals worth $3.9M as of Q1 2026.
  • Bank of America bought 27,179 Rigel Pharmaceuticals shares in Q1 2026, an estimated $913K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3645 holding.
  • Bank of America first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Rigel Pharmaceuticals position peaked at $5.01M in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.